The Company’s Goodwill balance as of January 31, 2026 and August 2, 2025 was $19 million, net of accumulated goodwill impairment charges of $727 million, and was only attributable to the Natural reporting unit. There were no goodwill impairment charges during fiscal 2026 and 2025 year-to-date. Changes in the carrying value of Goodwill for fiscal 2026 and 2025 year-to-date were due to changes in foreign exchange rates.


	January 31, 2026						August 2, 2025
(in millions)	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Amortizing intangible assets:
Customer relationships	$	1,007	$	501	$	506	$	1,007	$	472	$	535
Pharmacy prescription files	33		33		—		33		32		1
Operating lease intangibles	3		3		—		3		3		—
Trademarks and tradenames	85		74		11		85		70		15
Total amortizing intangible assets	1,128		611		517		1,128		577		551
Indefinite lived intangible assets:
Trademarks and tradenames	25		—		25		25		—		25
Intangibles assets, net	$	1,153	$	611	$	542	$	1,153	$	577	$	576

Amortization expense was $16 million and $18 million for the second quarters of fiscal 2026 and 2025, respectively, and $34 million and $36 million for fiscal 2026 and 2025 year-to-date, respectively. The estimated future amortization expense for each of the next five fiscal years and thereafter on amortizing intangible assets existing as of January 31, 2026 is as shown below: